Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo
Enterovirus infections can cause hand, foot, and mouth disease (HFDM), aseptic meningitis, encephalitis, myocarditis, and acute flaccid myelitis, leading to death of infants and young children. However, no specific antiviral drug is currently available for the treatment of this type of infection. Th...
Main Authors: | Yuexiang Li, Miaomiao Liu, Yunzheng Yan, Zhuang Wang, Qingsong Dai, Xiaotong Yang, Xiaojia Guo, Wei Li, Xingjuan Chen, Ruiyuan Cao, Wu Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/6/1142 |
Similar Items
-
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
by: Mohd. Imran, et al.
Published: (2021-09-01) -
The pill of recovery; Molnupiravir for treatment of COVID-19 patients; a systematic review
by: Lina Kamal, et al.
Published: (2022-05-01) -
Molnupiravir: A new candidate for COVID‐19 treatment
by: Fariba Pourkarim, et al.
Published: (2022-02-01) -
Molnupiravir: From Hope to Epic Fail?
by: Daniele Focosi
Published: (2022-11-01) -
Combination Therapy with UV-4B and Molnupiravir Enhances SARS-CoV-2 Suppression
by: Evelyn J. Franco, et al.
Published: (2023-05-01)